It has been reported that the inhibition of hypothalamic inflammation leads to a reduction in obesity-induced fasting hyperglycemia derived from abnormal gluconeogenesis and insulin resistance in the liver (Milanski et al., 2012). Here, INS is linked to Hyperglycemia.